Which has better earnings & valuation, GDRX or HTFL?

GoodRx has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio GoodRx $796.85M 1.41 $30.44M $0.04 82.00 Heartflow $176.03M 24.36 -$116.79M -$1.83 N/A

Is GDRX or HTFL more profitable?

GoodRx has a net margin of 2.07% compared to Heartflow's net margin of -55.82%. GoodRx's return on equity of 7.22% beat Heartflow's return on equity. Company Net Margins Return on Equity Return on Assets GoodRx 2.07% 7.22% 2.53% Heartflow -55.82% -23.52% -18.66%

Does the media refer more to GDRX or HTFL?

In the previous week, GoodRx and GoodRx both had 3 articles in the media. GoodRx's average media sentiment score of 0.51 beat Heartflow's score of -0.03 indicating that GoodRx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GoodRx 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Heartflow 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable earnings & valuation, SDGR or GDRX?

GoodRx has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Schrodinger $255.87M 8.74 -$103.26M -$0.74 N/A GoodRx $796.85M 1.41 $30.44M $0.04 82.00

Is SDGR or GDRX more profitable?

GoodRx has a net margin of 2.07% compared to Schrodinger's net margin of -20.98%. GoodRx's return on equity of 7.22% beat Schrodinger's return on equity. Company Net Margins Return on Equity Return on Assets Schrodinger -20.98% -16.37% -8.19% GoodRx 2.07% 7.22% 2.53%

Does the media prefer SDGR or GDRX?

In the previous week, Schrodinger had 1 more articles in the media than GoodRx. MarketBeat recorded 4 mentions for Schrodinger and 3 mentions for GoodRx. Schrodinger's average media sentiment score of 0.86 beat GoodRx's score of 0.51 indicating that Schrodinger is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Schrodinger 2 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive GoodRx 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings and valuation, GDRX or CERT?

GoodRx has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio GoodRx $796.85M 1.41 $30.44M $0.04 82.00 Certara $418.84M 3.41 -$1.60M -$0.45 N/A

Is GDRX or CERT more profitable?

GoodRx has a net margin of 2.07% compared to Certara's net margin of -16.75%. GoodRx's return on equity of 7.22% beat Certara's return on equity. Company Net Margins Return on Equity Return on Assets GoodRx 2.07% 7.22% 2.53% Certara -16.75% 3.86% 2.65%

Does the media favor GDRX or CERT?

In the previous week, Certara had 2 more articles in the media than GoodRx. MarketBeat recorded 5 mentions for Certara and 3 mentions for GoodRx. Certara's average media sentiment score of 0.63 beat GoodRx's score of 0.51 indicating that Certara is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GoodRx 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Certara 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation and earnings, TDOC or GDRX?

GoodRx has lower revenue, but higher earnings than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Teladoc Health $2.53B 0.40 -$200.32M -$0.99 N/A GoodRx $796.85M 1.41 $30.44M $0.04 82.00

Is TDOC or GDRX more profitable?

GoodRx has a net margin of 2.07% compared to Teladoc Health's net margin of -7.13%. GoodRx's return on equity of 7.22% beat Teladoc Health's return on equity. Company Net Margins Return on Equity Return on Assets Teladoc Health -7.13% -12.15% -5.83% GoodRx 2.07% 7.22% 2.53%

Does the media favor TDOC or GDRX?

In the previous week, Teladoc Health had 1 more articles in the media than GoodRx. MarketBeat recorded 4 mentions for Teladoc Health and 3 mentions for GoodRx. Teladoc Health's average media sentiment score of 0.72 beat GoodRx's score of 0.51 indicating that Teladoc Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Teladoc Health 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive GoodRx 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation & earnings, GDRX or HSTM?

GoodRx has higher revenue and earnings than HealthStream. HealthStream is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio GoodRx $796.85M 1.41 $30.44M $0.04 82.00 HealthStream $304.06M 2.96 $18.34M $0.72 42.81

Is GDRX or HSTM more profitable?

HealthStream has a net margin of 6.60% compared to GoodRx's net margin of 2.07%. GoodRx's return on equity of 7.22% beat HealthStream's return on equity. Company Net Margins Return on Equity Return on Assets GoodRx 2.07% 7.22% 2.53% HealthStream 6.60% 6.81% 4.64%

Does the media refer more to GDRX or HSTM?

In the previous week, GoodRx and GoodRx both had 3 articles in the media. HealthStream's average media sentiment score of 0.85 beat GoodRx's score of 0.51 indicating that HealthStream is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GoodRx 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive HealthStream 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

GoodRx (GDRX) Competitors

$3.28 +0.01 (+0.31%)

Closing price 10/2/2026 04:00 PM Eastern

Extended Trading

$3.28 +0.01 (+0.15%)

As of 10/2/2026 07:30 PM Eastern

Compare

GDRX vs. HTFL, SDGR, CERT, TDOC, and HSTM

Should you buy GoodRx stock or one of its competitors? GoodRx's main competitors and comparable companies include Heartflow (HTFL), Schrodinger (SDGR), Certara (CERT), Teladoc Health (TDOC), and HealthStream (HSTM). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does GoodRx compare to Heartflow?

GoodRx (NASDAQ:GDRX) and Heartflow (NASDAQ:HTFL) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, risk, valuation, media sentiment, institutional ownership, earnings and profitability.

GoodRx currently has a consensus target price of $4.23, suggesting a potential upside of 28.88%. Heartflow has a consensus target price of $46.25, suggesting a potential downside of 6.22%. Given GoodRx's higher probable upside, research analysts clearly believe GoodRx is more favorable than Heartflow.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GoodRx	3 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.08
Heartflow	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75

63.8% of GoodRx shares are held by institutional investors. 5.9% of GoodRx shares are held by company insiders. Comparatively, 7.7% of Heartflow shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, GoodRx and GoodRx both had 3 articles in the media. GoodRx's average media sentiment score of 0.51 beat Heartflow's score of -0.03 indicating that GoodRx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
GoodRx	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Heartflow	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

GoodRx has a net margin of 2.07% compared to Heartflow's net margin of -55.82%. GoodRx's return on equity of 7.22% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GoodRx	2.07%	7.22%	2.53%
Heartflow	-55.82%	-23.52%	-18.66%

GoodRx has a beta of 1.69, meaning that its share price is 69% more volatile than the broader market. Comparatively, Heartflow has a beta of 2.73, meaning that its share price is 173% more volatile than the broader market.

GoodRx has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GoodRx	$796.85M	1.41	$30.44M	$0.04	82.00
Heartflow	$176.03M	24.36	-$116.79M	-$1.83	N/A

Summary

GoodRx beats Heartflow on 10 of the 16 factors compared between the two stocks.

How does GoodRx compare to Schrodinger?

Schrodinger (NASDAQ:SDGR) and GoodRx (NASDAQ:GDRX) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, profitability, dividends, valuation, analyst recommendations, earnings and media sentiment.

GoodRx has a net margin of 2.07% compared to Schrodinger's net margin of -20.98%. GoodRx's return on equity of 7.22% beat Schrodinger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Schrodinger	-20.98%	-16.37%	-8.19%
GoodRx	2.07%	7.22%	2.53%

Schrodinger has a beta of 1.62, meaning that its share price is 62% more volatile than the broader market. Comparatively, GoodRx has a beta of 1.69, meaning that its share price is 69% more volatile than the broader market.

GoodRx has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Schrodinger	$255.87M	8.74	-$103.26M	-$0.74	N/A
GoodRx	$796.85M	1.41	$30.44M	$0.04	82.00

Schrodinger currently has a consensus target price of $20.80, indicating a potential downside of 31.38%. GoodRx has a consensus target price of $4.23, indicating a potential upside of 28.88%. Given GoodRx's higher probable upside, analysts clearly believe GoodRx is more favorable than Schrodinger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Schrodinger	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
GoodRx	3 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.08

In the previous week, Schrodinger had 1 more articles in the media than GoodRx. MarketBeat recorded 4 mentions for Schrodinger and 3 mentions for GoodRx. Schrodinger's average media sentiment score of 0.86 beat GoodRx's score of 0.51 indicating that Schrodinger is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Schrodinger	2 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
GoodRx	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

79.1% of Schrodinger shares are owned by institutional investors. Comparatively, 63.8% of GoodRx shares are owned by institutional investors. 10.1% of Schrodinger shares are owned by insiders. Comparatively, 5.9% of GoodRx shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

GoodRx beats Schrodinger on 10 of the 16 factors compared between the two stocks.

How does GoodRx compare to Certara?

GoodRx (NASDAQ:GDRX) and Certara (NASDAQ:CERT) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, dividends, valuation, profitability, risk, earnings, institutional ownership and media sentiment.

GoodRx has a beta of 1.69, suggesting that its share price is 69% more volatile than the broader market. Comparatively, Certara has a beta of 1.42, suggesting that its share price is 42% more volatile than the broader market.

In the previous week, Certara had 2 more articles in the media than GoodRx. MarketBeat recorded 5 mentions for Certara and 3 mentions for GoodRx. Certara's average media sentiment score of 0.63 beat GoodRx's score of 0.51 indicating that Certara is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
GoodRx	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Certara	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

GoodRx has a net margin of 2.07% compared to Certara's net margin of -16.75%. GoodRx's return on equity of 7.22% beat Certara's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GoodRx	2.07%	7.22%	2.53%
Certara	-16.75%	3.86%	2.65%

63.8% of GoodRx shares are owned by institutional investors. Comparatively, 74.0% of Certara shares are owned by institutional investors. 5.9% of GoodRx shares are owned by insiders. Comparatively, 1.1% of Certara shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

GoodRx presently has a consensus target price of $4.23, indicating a potential upside of 28.88%. Certara has a consensus target price of $8.45, indicating a potential downside of 9.72%. Given GoodRx's higher possible upside, research analysts clearly believe GoodRx is more favorable than Certara.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GoodRx	3 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.08
Certara	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.42

GoodRx has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GoodRx	$796.85M	1.41	$30.44M	$0.04	82.00
Certara	$418.84M	3.41	-$1.60M	-$0.45	N/A

Summary

GoodRx beats Certara on 9 of the 16 factors compared between the two stocks.

How does GoodRx compare to Teladoc Health?

Teladoc Health (NYSE:TDOC) and GoodRx (NASDAQ:GDRX) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, profitability, earnings, analyst recommendations, institutional ownership, valuation and media sentiment.

Teladoc Health has a beta of 2.14, meaning that its stock price is 114% more volatile than the broader market. Comparatively, GoodRx has a beta of 1.69, meaning that its stock price is 69% more volatile than the broader market.

GoodRx has lower revenue, but higher earnings than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Teladoc Health	$2.53B	0.40	-$200.32M	-$0.99	N/A
GoodRx	$796.85M	1.41	$30.44M	$0.04	82.00

In the previous week, Teladoc Health had 1 more articles in the media than GoodRx. MarketBeat recorded 4 mentions for Teladoc Health and 3 mentions for GoodRx. Teladoc Health's average media sentiment score of 0.72 beat GoodRx's score of 0.51 indicating that Teladoc Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Teladoc Health	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
GoodRx	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Teladoc Health presently has a consensus target price of $7.54, suggesting a potential upside of 36.12%. GoodRx has a consensus target price of $4.23, suggesting a potential upside of 28.88%. Given Teladoc Health's stronger consensus rating and higher probable upside, research analysts clearly believe Teladoc Health is more favorable than GoodRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teladoc Health	1 Sell rating(s)	10 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.25
GoodRx	3 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.08

76.8% of Teladoc Health shares are owned by institutional investors. Comparatively, 63.8% of GoodRx shares are owned by institutional investors. 0.7% of Teladoc Health shares are owned by insiders. Comparatively, 5.9% of GoodRx shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

GoodRx has a net margin of 2.07% compared to Teladoc Health's net margin of -7.13%. GoodRx's return on equity of 7.22% beat Teladoc Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Teladoc Health	-7.13%	-12.15%	-5.83%
GoodRx	2.07%	7.22%	2.53%

Summary

Teladoc Health and GoodRx tied by winning 8 of the 16 factors compared between the two stocks.

How does GoodRx compare to HealthStream?

GoodRx (NASDAQ:GDRX) and HealthStream (NASDAQ:HSTM) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership, media sentiment and risk.

In the previous week, GoodRx and GoodRx both had 3 articles in the media. HealthStream's average media sentiment score of 0.85 beat GoodRx's score of 0.51 indicating that HealthStream is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
GoodRx	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
HealthStream	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

63.8% of GoodRx shares are owned by institutional investors. Comparatively, 69.6% of HealthStream shares are owned by institutional investors. 5.9% of GoodRx shares are owned by insiders. Comparatively, 20.4% of HealthStream shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

HealthStream has a net margin of 6.60% compared to GoodRx's net margin of 2.07%. GoodRx's return on equity of 7.22% beat HealthStream's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GoodRx	2.07%	7.22%	2.53%
HealthStream	6.60%	6.81%	4.64%

GoodRx presently has a consensus target price of $4.23, suggesting a potential upside of 28.88%. HealthStream has a consensus target price of $27.00, suggesting a potential downside of 12.39%. Given GoodRx's stronger consensus rating and higher probable upside, equities analysts plainly believe GoodRx is more favorable than HealthStream.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GoodRx	3 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.08
HealthStream	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

GoodRx has a beta of 1.69, meaning that its share price is 69% more volatile than the broader market. Comparatively, HealthStream has a beta of 0.42, meaning that its share price is 58% less volatile than the broader market.

GoodRx has higher revenue and earnings than HealthStream. HealthStream is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GoodRx	$796.85M	1.41	$30.44M	$0.04	82.00
HealthStream	$304.06M	2.96	$18.34M	$0.72	42.81

Summary

GoodRx beats HealthStream on 8 of the 15 factors compared between the two stocks.

Get GoodRx News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GDRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

GDRX vs. The Competition

Export

Metric	GoodRx	Healthcare Technology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.12B	$1.74B	$7.15B	$13.28B
Dividend Yield	N/A	3.97%	2.54%	17.33%
P/E Ratio	82.02	20.33	274.71	26.04
Price / Sales	1.41	87.61	656.46	105.16
Price / Cash	8.20	31.81	78.87	52.62
Price / Book	1.81	6.16	10.93	6.31
Net Income	$30.44M	-$18.66M	$3.51B	$362.16M
7 Day Performance	-2.09%	-2.24%	-2.00%	-1.66%
1 Month Performance	-5.75%	-1.21%	-6.19%	-4.68%
1 Year Performance	-27.59%	-21.68%	8.03%	1.57%

GoodRx Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
GDRX GoodRx	3.8374 of 5 stars	$3.28 +0.3%	$4.23 +28.9%	-27.6%	$1.12B	$796.85M	82.02	697	News Coverage Positive News
HTFL Heartflow	1.6624 of 5 stars	$49.92 +1.5%	$46.25 -7.4%	+31.0%	$4.28B	$176.03M	N/A	843	Analyst Upgrade
SDGR Schrodinger	1.3487 of 5 stars	$29.50 +2.3%	$20.80 -29.5%	+47.2%	$2.13B	$255.87M	N/A	850
CERT Certara	1.5993 of 5 stars	$9.13 +0.2%	$8.28 -9.3%	-28.4%	$1.39B	$418.84M	N/A	1,576	Analyst Upgrade
TDOC Teladoc Health	3.2941 of 5 stars	$5.90 -3.2%	$7.54 +27.8%	-38.5%	$1.11B	$2.53B	N/A	5,600

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:GDRX) was last updated on 10/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

GoodRx (GDRX) Competitors